Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4227334
Max Phase: Preclinical
Molecular Formula: C24H26FN3O3
Molecular Weight: 423.49
Molecule Type: Small molecule
Associated Items:
ID: ALA4227334
Max Phase: Preclinical
Molecular Formula: C24H26FN3O3
Molecular Weight: 423.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)c1c(N2CCN(c3ccccc3F)CC2)c2ccccc2n(CC)c1=O
Standard InChI: InChI=1S/C24H26FN3O3/c1-3-28-19-11-7-5-9-17(19)22(21(23(28)29)24(30)31-4-2)27-15-13-26(14-16-27)20-12-8-6-10-18(20)25/h5-12H,3-4,13-16H2,1-2H3
Standard InChI Key: HIZBHOLMOKPORQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 423.49 | Molecular Weight (Monoisotopic): 423.1958 | AlogP: 3.66 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.78 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.05 | CX LogP: 3.45 | CX LogD: 3.45 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.59 | Np Likeness Score: -1.20 |
1. Banu S, Bollu R, Naseema M, Gomedhika PM, Nagarapu L, Sirisha K, Kumar CG, Gundasw SK.. (2018) A novel templates of piperazinyl-1,2-dihydroquinoline-3-carboxylates: Synthesis, anti-microbial evaluation and molecular docking studies., 28 (7): [PMID:29534925] [10.1016/j.bmcl.2018.03.007] |
Source(1):